Leading specialist of the University of Basel (Switzerland) heads RUDN research laboratory

Leading specialist of the University of Basel (Switzerland) heads RUDN research laboratory

Professor Jörg Huwyler from the University of Basel headed the laboratory for the study of innovative methods of drug delivery.

Professor Jörg Huwyler is a leading specialist in targeted drug delivery, member of the Swiss Academy of Pharmaceutical Sciences, author of 13 patents, 142 peer-reviewed scientific articles (h-index: 38). One of his innovative publications on the delivery of antitumor agents to the rat brain due to immunoliposomes has been cited more than 650 times.

The expert calls the pharmaceutical technology a translation science, as it very often helps to transfer the results of basic research to clinical applications. Several drugs developed in his Swiss laboratory are used in clinical trials.

The joint team of the scientific laboratory for the study of innovative methods of drug delivery is already participating in the project to increase the bioavailability of the drug for the treatment of AIDS by using hot melt extrusion.

The work is also carried out in the field of creating a combined diagnostic drug that will enable drugs adequate choice and dosage regimen in the treatment of cancer.

One of the goals of RUDN research is the development of individual approaches in the treatment of cancer patients through the use of innovative pharmaceutical technologies and metabolic tools - the transition to personalized medicine.

News
All news
Science
27 Apr
Vocabulary Size Affects One’s Ability to Differentiate Between Vowels in a Foreign Language, Say Linguists from RUDN University

A team of linguists from RUDN University established that a person’s ability to accurately differentiate between vowel sounds of a foreign language correlates with the size of their vocabulary in said language.

Science
22 Apr
A Bifidobacterial Protein Capable of Reducing Inflammation in Patients with COVID-19 and Other Diseases Was Discovered by a RUDN University Geneticist

A geneticist from RUDN University studied the effect of Bifidobacterium (intestinal bacteria) on the inflammatory process and discovered that their surface protein is capable of stopping excessive or uncontrollable inflammation, like the one observed in COVID-19 patients. A fragment of this protein can be used as an anti-inflammatory medication when treating coronavirus and other diseases.

Science
13 Apr
RUDN University mathematician suggested new approach to cooperative game

A mathematician from RUDN University developed a matrix representation of set functions. This approach is vivid and easy to check, and it makes the calculations easier. Among other things, the new development can be applied to cooperative game theory.